We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Intuitive Surgical, Inc. (ISRG) Surpasses Market Returns: Some Facts Worth Knowing
Read MoreHide Full Article
In the latest trading session, Intuitive Surgical, Inc. (ISRG - Free Report) closed at $452.35, marking a +2.11% move from the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.01%. On the other hand, the Dow registered a gain of 0.51%, and the technology-centric Nasdaq decreased by 0.28%.
Shares of the company have depreciated by 2.53% over the course of the past month, underperforming the Medical sector's gain of 4.67%, and the S&P 500's gain of 4.83%.
The investment community will be paying close attention to the earnings performance of Intuitive Surgical, Inc. in its upcoming release. The company is predicted to post an EPS of $1.99, indicating a 8.15% growth compared to the equivalent quarter last year. At the same time, our most recent consensus estimate is projecting a revenue of $2.41 billion, reflecting a 18.2% rise from the equivalent quarter last year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $8.17 per share and revenue of $9.78 billion, indicating changes of +11.31% and +17.06%, respectively, compared to the previous year.
Investors might also notice recent changes to analyst estimates for Intuitive Surgical, Inc. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.03% decrease. Intuitive Surgical, Inc. is currently a Zacks Rank #4 (Sell).
In the context of valuation, Intuitive Surgical, Inc. is at present trading with a Forward P/E ratio of 54.23. For comparison, its industry has an average Forward P/E of 24.05, which means Intuitive Surgical, Inc. is trading at a premium to the group.
Investors should also note that ISRG has a PEG ratio of 3.72 right now. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. By the end of yesterday's trading, the Medical - Instruments industry had an average PEG ratio of 2.5.
The Medical - Instruments industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 81, finds itself in the top 33% echelons of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Intuitive Surgical, Inc. (ISRG) Surpasses Market Returns: Some Facts Worth Knowing
In the latest trading session, Intuitive Surgical, Inc. (ISRG - Free Report) closed at $452.35, marking a +2.11% move from the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.01%. On the other hand, the Dow registered a gain of 0.51%, and the technology-centric Nasdaq decreased by 0.28%.
Shares of the company have depreciated by 2.53% over the course of the past month, underperforming the Medical sector's gain of 4.67%, and the S&P 500's gain of 4.83%.
The investment community will be paying close attention to the earnings performance of Intuitive Surgical, Inc. in its upcoming release. The company is predicted to post an EPS of $1.99, indicating a 8.15% growth compared to the equivalent quarter last year. At the same time, our most recent consensus estimate is projecting a revenue of $2.41 billion, reflecting a 18.2% rise from the equivalent quarter last year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $8.17 per share and revenue of $9.78 billion, indicating changes of +11.31% and +17.06%, respectively, compared to the previous year.
Investors might also notice recent changes to analyst estimates for Intuitive Surgical, Inc. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.03% decrease. Intuitive Surgical, Inc. is currently a Zacks Rank #4 (Sell).
In the context of valuation, Intuitive Surgical, Inc. is at present trading with a Forward P/E ratio of 54.23. For comparison, its industry has an average Forward P/E of 24.05, which means Intuitive Surgical, Inc. is trading at a premium to the group.
Investors should also note that ISRG has a PEG ratio of 3.72 right now. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. By the end of yesterday's trading, the Medical - Instruments industry had an average PEG ratio of 2.5.
The Medical - Instruments industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 81, finds itself in the top 33% echelons of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.